SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group (English, French, XML)
View metadata and access the original English/French XML file: SARS-CoV-2 antibody seroprevalence from past infection, by region, sex and age group.
- Format
- XML
- Access
- file-only
- Publisher-reported update
- 2025-05-26
Dried blood spot testing was used to detect antibodies against SARS-CoV-2, the virus that causes COVID-19. The proportion of Canadians who have antibodies from infection is referred to as the seroprevalence of SARS-CoV-2.
Data overview
- Formats
- XML
- File languages
- English, French
- Available actions
- Access original file